Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma.

Han, Myung-Hoon; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Won, Yu Deok; Nam, Gun He; Kim, Choong Hyun

Han, Myung-Hoon; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Won, Yu Deok; Nam, Gun He; Kim, Choong Hyun.

Afiliación

Han MH; Department of Neurosurgery, Hanyang University Guri Hospital, Guri, South Korea.
Kim JM; Department of Neurosurgery, Hanyang University Guri Hospital, Guri, South Korea.
Cheong JH; Department of Neurosurgery, Hanyang University Guri Hospital, Guri, South Korea.
Ryu JI; Department of Neurosurgery, Hanyang University Guri Hospital, Guri, South Korea.
Won YD; Department of Neurosurgery, Hanyang University Guri Hospital, Guri, South Korea.
Nam GH; Development Division, GC Cell Corp., Yongin-si, South Korea.
Kim CH; Department of Neurosurgery, Hanyang University Guri Hospital, Guri, South Korea.

Front Oncol ; 12: 851628, 2022.

Article en En | MEDLINE | ID: mdl-35463313

Palabras clave

adoptive cell transfer; cytokine-induced killer cell (CIK); glioblastoma multiforme; immunotherapy; overall survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google